innat
immun
respons
first
strategi
host
defens
invad
pathogen
tissu
damag
activ
occur
conserv
structur
surfac
pathogen
associ
tissu
damag
call
pathogen
associ
molecular
pattern
pamp
damageassoci
molecular
pattern
damp
respect
recogn
cellassoci
solubl
molecul
known
pattern
recognit
molecul
prm
among
solubl
prm
pentraxin
superfamili
evolutionarili
conserv
molecul
multifunct
role
innat
immun
inflamm
regul
complement
activ
opson
pathogen
creactiv
protein
crp
serum
amyloid
p
compon
sap
short
classic
pentraxin
crp
mainli
produc
hepatocyt
acut
phase
protein
man
well
mammalian
speci
mous
respons
interleukin
il
wherea
sap
short
pentraxin
act
acut
phase
protein
mous
pentraxin
prototyp
long
pentraxin
subfamili
origin
identifi
tnfinduc
gene
produc
differ
cell
type
respons
primari
proinflammatori
stimuli
microbi
moieti
essenti
mediat
innat
resist
select
pathogen
fungal
bacteri
viral
origin
discuss
elsewher
involv
regul
inflamm
tissu
remodel
cancer
review
main
biolog
featur
focus
structur
involv
steril
condit
tissu
damag
cancer
provid
evid
microbi
matrix
recognit
evolutionarili
conserv
properti
share
humor
innat
immun
molecul
human
murin
gene
map
chromosom
organ
three
exon
first
two
code
leader
peptid
ntermin
domain
third
code
cterminalpentraxin
domain
figur
mainli
induc
proinflammatori
cytokin
tlr
agonist
microbi
compon
eg
lp
lipoarabinomannan
outer
membran
protein
select
gramneg
bacteria
intact
microorgan
figur
express
induc
wide
varieti
cell
type
includ
fibroblast
endotheli
cell
myeloid
cell
monocyt
macrophag
dendrit
cell
dc
synovi
cell
chondrocyt
adipocyt
glial
mesangi
cell
epitheli
cell
retin
cell
figur
high
densiti
oxid
low
densiti
lipoprotein
hdl
oxldl
induc
product
endotheli
cell
primari
vascular
smooth
muscl
cell
smc
microbi
ligand
stimul
releas
neutrophil
protein
mostli
produc
myeloid
precursor
constitut
store
specif
granul
among
peripher
blood
mononuclear
cell
monocyt
expos
inflammatori
cytokin
lp
produc
mrna
express
neg
regul
dexamethason
prostaglandin
also
induc
ovulatori
stimuli
granulosa
cell
releas
contribut
structur
architectur
cumulu
oophoru
extracellular
matrix
express
product
regul
differ
signal
pathway
mainli
depend
cell
type
stimuli
pathway
control
express
condit
receptor
tlrdepend
inflamm
induct
protein
lung
epitheli
cell
involv
cjun
ntermin
kinas
jnk
pathway
hdlinduc
product
endotheli
cell
requir
activ
pathway
gcoupl
lysosphingolipid
receptor
express
human
gene
physiolog
inflammatori
condit
also
regul
epigenet
mechan
hypermethyl
promot
region
enhanc
encompass
second
exon
enhanc
figur
associ
gene
silenc
select
human
tumor
eg
colon
rectal
cancer
leiomyosarcoma
consist
hypomethyl
regulatori
element
correl
higher
normal
protein
level
plasma
coronari
arteri
diseas
patient
recent
studi
character
epigenet
mechan
context
differ
express
cell
includ
macrophag
fibroblast
address
epigenet
modif
occur
gene
colorect
cancer
crc
investig
identifi
second
enhanc
locat
kb
upstream
gene
promot
enhanc
figur
silico
chip
analysi
reveal
bind
sever
transcript
factor
enhanc
mani
includ
subunit
rela
cjun
cfo
involv
activ
inflammatori
immun
respons
also
known
control
activ
promot
figur
enhanc
found
bind
stimul
macrophag
suggest
regulatori
element
could
import
activ
tissuespecif
transcript
factor
howev
enhanc
could
direct
role
activ
express
sinc
chip
analysi
show
interact
member
transcript
preiniti
complex
pic
furthermor
hypermethyl
enhanc
associ
gene
silenc
colorect
cancer
figur
interestingli
vitro
treatment
macrophag
glucocorticoid
hormon
dexamethason
result
polar
associ
immun
suppress
tumor
progress
noteworthi
one
main
marker
phenotyp
activ
thu
suggest
downregul
could
involv
carcinogenesi
see
amongst
singl
nucleotid
polymorph
snp
three
collect
form
haplotyp
block
found
associ
suscept
infect
includ
caus
aspergillu
fumigatu
mycobacterium
tuberculosi
pseudomona
aeruginosa
two
snp
locat
intron
noncod
region
intron
intron
third
exon
polymorph
caus
amino
acid
substitut
posit
epidemiolog
studi
found
correl
three
snp
plasma
level
howev
molecular
mechan
respons
associ
still
poorli
understood
regard
individu
carri
allel
lower
system
concentr
might
due
faster
rate
mrna
degrad
propos
cunha
et
al
altern
reduc
activ
second
enhanc
gene
encompass
snp
current
possibl
exclud
direct
local
effect
amino
acid
substitut
protein
structur
therefor
function
multimer
glycoprotein
whose
protom
subunit
compris
amino
acid
protein
primari
sequenc
highli
conserv
evolut
ident
human
murin
like
due
earli
select
endur
mainten
phylogenesi
fundament
structurefunct
relationship
analog
member
long
pentraxin
subfamili
includ
guinea
pig
apexin
rat
human
murin
neuron
pentraxin
also
known
narp
put
integr
membran
pentraxin
nrp
protom
organ
ntermin
region
amino
acid
long
ctermin
domain
homolog
short
pentraxin
crp
sap
figur
ntermin
domain
obviou
similar
protein
known
structur
howev
secondari
structur
predict
indic
domain
mostli
compris
element
three
like
organ
coiledcoil
furthermor
ntermin
end
domain
amino
acid
predict
intrins
disord
properti
might
provid
protein
structur
function
versatil
thu
contribut
remark
complex
interact
network
ctermin
domain
share
short
pentraxin
consider
degre
homolog
similar
allow
gener
model
base
crystal
structur
crp
sap
indic
adopt
roll
topolog
stabil
two
intrachain
disulfid
bond
two
addit
cystein
residu
ie
involv
intra
interchain
disulfid
conjunct
interchain
bond
made
cystein
residu
ntermin
domain
support
quaternari
structur
matur
protein
figur
pentraxin
domain
bear
singl
nglycosyl
site
recombin
form
protein
cho
cell
fulli
occupi
complex
type
oligosaccharid
mainli
fucosyl
sialyl
biantennari
sugar
minor
fraction
triand
tetraantennari
glycan
nlink
complex
type
glycosyl
occur
natur
protein
made
human
cell
mediat
biolog
function
includ
inhibit
influenza
viru
hemagglutin
recognit
pselectin
furthermor
protein
glycosyl
major
regard
sialyl
modul
interact
regulatori
effect
complement
activ
via
classic
pathway
specul
molecular
crosstalk
rang
divers
ligand
involv
common
glycan
code
wherebi
tissu
microenvironmentspecif
chang
protein
glycosyl
profil
might
regul
biolog
properti
see
review
modular
ie
n
cdomain
submodular
ie
coiledcoil
intrins
disord
region
ndomain
natur
protom
like
endow
structur
versatil
requir
support
divers
interact
therebi
biolog
function
regard
ntermin
region
protein
contain
bind
site
fibroblast
growth
factor
protein
plasminogen
plg
fibrin
conidia
fumigatu
pselectin
mostli
interact
pentraxinlik
domain
wherea
domain
implic
recognit
complement
factor
h
addit
multidomain
organ
complex
quaternari
structur
highord
oligom
stabil
disulfid
bond
mass
spectrometri
sitedirect
mutagenesi
indic
made
coval
octam
ie
molecular
mass
kda
interchain
disulfid
bridg
figur
lowresolut
model
base
data
electron
microscopi
small
angl
xray
scatter
show
eight
protom
fold
elong
molecul
two
differ
size
domain
interconnect
stalk
region
pseudo
fold
symmetri
along
longitudin
axi
quaternari
structur
uniqu
among
pentraxin
crp
sap
share
prototyp
pentamer
planar
symmetri
pentraxin
form
octam
sap
limulu
polyphemu
howev
fold
doubli
stack
octamer
ring
addit
oligomer
organ
import
implic
ligand
bind
properti
exampl
octam
contain
two
bind
site
tetramer
recombin
form
ntermin
domain
recapitul
inhibitori
function
full
length
protein
toward
factor
angiogenesi
bone
deposit
howev
dimer
form
ntermin
domain
retain
bind
therebi
octamer
protein
like
endow
multipl
least
four
bind
site
ligand
act
nodal
molecul
crosslink
hyaluron
acid
extracellular
matrix
high
resolut
model
urgent
need
disentangl
structur
complex
long
pentraxin
shed
light
structurefunct
relationship
remark
differ
classic
describ
short
pentraxin
beyond
role
first
line
resist
pathogen
innat
immun
involv
initi
process
tissu
repair
cellular
arm
innat
immun
system
sens
specif
damp
regul
inflammatori
respons
site
damag
humor
arm
innat
immun
differ
complex
role
rang
clearanc
apoptot
cell
regul
immun
cell
migrat
activ
regul
remodel
cell
activ
instanc
sap
regul
fibrosi
inhibit
altern
activ
macrophag
via
modul
immun
cell
activ
via
dcsign
pentraxin
compon
complement
system
also
interact
element
present
extracellular
matrix
ecm
thu
suggest
addit
regulatori
role
innat
immun
system
tissu
respons
injuri
hand
differ
ecm
compon
fibronectin
mindin
osteopontin
vitronectin
interact
microb
opson
activ
thu
suggest
close
evolutionari
link
recognit
microbi
moieti
ecm
compon
differ
mous
model
noninfecti
tissu
damag
defici
long
pentraxin
associ
alter
thrombot
respons
lesion
increas
deposit
persist
fibrin
follow
increas
collagen
deposit
figur
follow
tissu
damag
induc
blood
local
respons
tlr
activ
amplif
interestingli
report
among
gene
induc
thrombin
monocyt
site
wound
releas
neutrophil
local
clot
pericellular
matrix
macrophag
cell
mesenchym
origin
collect
invad
wound
site
skin
wound
associ
increas
deposit
fibrin
follow
increas
deposit
collagen
fibroplasia
epitheli
hyperplasia
delay
heal
prematur
contract
wound
observ
mice
agreement
augment
content
plateletderiv
factor
eg
thrombin
serotonin
pdgf
known
respons
skin
wound
contract
smc
locat
panniculu
carnosu
inde
administr
pharmacolog
inhibitor
coagul
platelet
activ
revert
defect
includ
prematur
wound
contract
increas
collagen
deposit
therefor
alter
haemostat
fibrinolyt
respons
trigger
alter
associ
skin
wound
heal
liver
injuri
local
necroinflammatori
area
fibrot
portal
tract
associ
neutrophil
macrophag
mesenchym
stromal
cell
msc
set
associ
increas
centrilobular
thrombosi
fibrin
deposit
necroinflammatori
area
follow
sever
impair
repair
fibrosi
assess
increas
fibroblast
cell
collagen
deposit
similar
abnorm
report
differ
model
lung
injuri
addit
play
protect
role
murin
model
ischem
injuri
brain
involv
resolut
edema
glial
scar
format
administr
revert
interstiti
fibrosi
mous
model
acut
kidney
injuri
fibrin
deposit
tissu
injuri
subsequ
time
remov
essenti
sever
aspect
tissu
repair
major
organ
well
wide
rang
patholog
condit
context
defect
fibrinolysi
describ
etiopatholog
factor
lead
reduc
remodel
alter
connect
tissu
format
macrophag
msc
enter
wound
site
invad
inflammatori
matrix
plasminmedi
mechan
allow
fibrin
remov
consequ
deposit
granul
tissu
rich
type
collagen
well
ecm
protein
alter
tissu
repair
observ
mice
attribut
defect
plasminmedi
invas
fibrinolysi
tissu
remodel
cell
name
macrophag
msc
also
vitro
macrophag
fibroblast
show
defect
fibrinolyt
activ
thu
suggest
contribut
progress
normal
effici
pericellular
fibrinolysi
promot
repair
shown
interact
specif
plg
fibrin
acid
ph
optim
rang
neutral
ph
figur
interestingli
interact
member
ficolin
collectin
famili
occur
fibrinogenlik
domain
collagen
domain
facilit
acid
microenviron
acidif
wound
site
occur
result
cellular
metabol
adapt
traumainduc
tissu
hypoperfus
function
relev
heal
outcom
involv
sever
process
includ
cell
adhes
migrat
prolifer
interact
fibrin
plg
occur
differ
site
ntermin
domain
interfer
interact
fibrin
plg
map
experi
interact
plg
kringl
domain
indispens
plg
initi
recruit
lysinerich
portion
fibrin
andor
cell
surfac
specif
bound
kringl
domain
interact
could
crucial
trigger
plg
conform
chang
allow
transit
molecul
closedinact
open
function
form
conform
transit
essenti
plg
convers
plasmin
oper
plg
activ
pa
central
fibrin
remov
thrombu
inde
cellfre
fibrinolysi
assay
interact
plg
determin
enhanc
plasminmedi
fibrin
gel
degrad
trigger
urokinas
pa
upa
tissuetyp
plasminogen
activ
tpa
acid
neutral
ph
plg
activ
neutral
proteas
depend
acid
ph
interact
fibrin
plg
ensur
occur
circul
rather
site
tissu
repair
thrombi
support
fibrinolysi
acid
environ
thu
acid
ph
act
switch
signal
function
figur
interact
fibrin
plg
restrict
sinc
similar
function
report
short
pentraxin
one
studi
report
interact
sap
fibrin
consequ
modul
vitro
format
clot
howev
underli
molecular
mechan
never
character
model
arteri
thrombosi
produc
vessel
wall
critic
protect
role
modul
thrombu
format
fibrinogen
preincub
significantli
reduc
platelet
aggreg
presenc
collagen
likewis
preincub
collagen
attenu
platelet
aggreg
presenc
fibrinogen
effect
depend
respect
ntermin
ctermin
domain
suggest
arteri
thrombosi
disfavor
prothrombot
activ
fibrinogen
collagen
interact
pselectin
tune
pselectindepend
neutrophil
extravas
howev
arteri
thrombosi
influenc
pselectindepend
plateletleukocyt
plateletendothelium
aggreg
although
initi
report
induc
tissu
factor
tf
express
endotheli
cell
monocyt
subsequ
vitro
vivo
studi
confirm
result
inde
thrombosi
model
tf
express
aorta
mice
control
similar
result
line
evid
play
protect
function
vascular
patholog
inde
overexpress
limit
neointim
thicken
rat
carotid
arteri
balloon
injuri
associ
augment
infarct
area
follow
myocardi
ischemiareperfus
injuri
increas
atherosclerosi
augment
macrophag
accumul
inflamm
atherosclerot
plaqu
administr
msc
acut
chronic
wound
improv
wound
heal
increas
granul
tissu
format
acceler
reepitheli
stimul
angiogenesi
paracrin
signal
thu
prompt
new
studi
treatment
nonheal
wound
result
burn
crohn
diseas
wound
skin
msc
act
potent
promot
tissu
repair
remodel
wherea
msc
show
compromis
recruit
invas
site
damag
due
defect
fibrinolysi
therefor
exert
compromis
therapeut
effect
caus
delay
heal
similar
result
obtain
mous
model
acid
aspirationdepend
acut
lung
injuri
mimick
acut
respiratori
distress
syndrom
ard
caus
aspir
gastric
content
mous
model
benefici
effect
treatment
msc
earli
acut
inflammatori
reaction
pulmonari
edema
longterm
fibrot
evolut
pulmonari
function
observ
administr
msc
less
effect
limit
pulmonari
edema
h
acid
aspir
associ
defect
fibrinolyt
activ
result
later
time
point
increas
pulmonari
fibrosi
therefor
signific
increas
lung
function
level
ddimer
significantli
increas
mice
treatment
msc
indic
abil
modul
pulmonari
fibrinolysi
thu
affect
fibrot
scar
administr
msc
result
decreas
lung
level
ddimer
compar
msc
thu
attribut
defect
fibrinolysi
observ
reduc
therapeut
effect
msc
recent
identifi
import
molecul
contribut
bone
homeostasi
remodel
homoeostat
condit
histolog
analysi
distal
femur
mice
show
differ
number
activ
trabecular
endost
trap
osteoclast
howev
microcomput
tomographi
show
lower
bone
volum
attribut
suppress
osteoblast
function
fractur
regener
model
tibia
diaphysi
mice
show
lower
bone
format
repair
rate
control
agreement
lower
percentag
miner
callou
tissu
lower
collagen
express
compar
control
condit
homeostasi
bone
repair
express
associ
nonhematopoieticnonendotheli
periost
cell
particular
osteoprogenitor
subset
express
earli
stage
bone
format
abundantli
accumul
bone
matrix
particip
osteoblastogenesi
skelet
remodel
agreement
properti
bind
prevent
activ
revers
neg
effect
osteoblast
differenti
bone
marrow
stromal
cell
vitro
ntermin
domain
alon
recapitul
activ
therefor
produc
osteoblast
lineag
cell
act
bone
protect
factor
import
unlock
osteoblast
matur
antagon
effect
bone
format
bone
format
fractur
repair
initi
around
extravascular
deposit
fibrinrich
matrix
subsequ
defect
fibrin
clearanc
fractur
site
sever
impair
heal
fibrinogen
deplet
plgdefici
anim
restor
normal
fractur
repair
thu
prove
ineffici
fibrin
turnov
essenti
bone
repair
therefor
studi
need
address
relev
modul
fibrinolyt
system
bone
repair
togeth
studi
provid
sever
line
evid
involv
tissu
remodel
repair
depend
recognit
matrix
molecul
highlight
connect
interplay
haemostasi
immun
figur
inflamm
compon
tumor
microenviron
promot
tumor
develop
growth
sinc
express
inflammatori
condit
act
tuner
complementactiv
leukocyt
recruit
hypothes
involv
cancerrel
inflamm
genet
studi
mice
show
caus
increas
suscept
mesenchym
epitheli
carcinogenesi
model
induc
sarcomagenesi
anthraceneterephthal
acid
dmbatpa
induc
skin
carcinogenesi
tumor
infiltr
macrophag
endotheli
cell
major
sourc
respons
local
produc
tumor
character
increas
macrophag
infiltr
proinflammatori
cytokin
product
complement
activ
angiogenesi
well
increas
oxid
dna
damag
genet
instabl
compar
wild
type
tumor
context
regul
complement
activ
interact
factor
h
complement
regul
consequ
macrophag
recruit
polar
figur
data
line
recent
studi
show
anaphylatoxin
may
contribut
cancerrel
inflamm
recruit
myeloid
suppressor
cell
promot
respons
neutrophil
thu
promot
colon
carcinogenesi
addit
regul
complement
shown
bind
select
fibroblast
growth
factor
fgf
includ
ntermin
domain
inhibit
fgfdepend
angiogen
respons
effect
shown
respons
antitumor
activ
fgfdepend
transplant
murin
tumor
includ
prostat
cancer
melanoma
fibrosarcoma
figur
role
antiangiogen
activ
address
far
primari
carcinogenesi
line
preclin
studi
human
promot
regulatori
region
shown
epigenet
modifi
hypermethyl
select
human
mesenchym
epitheli
cancer
esophag
squamou
cell
carcinoma
colorect
cancer
lead
silenc
protein
express
thu
genet
studi
mice
epigenet
studi
human
demonstr
behav
extrins
oncosuppressor
gene
act
level
complementmedi
macrophagesustain
tumor
promot
inflamm
contrast
genet
evid
outlin
sever
studi
perform
overexpress
cell
suggest
protein
may
play
protumorigen
role
promot
tumor
cell
migrat
invas
head
neck
tumor
cervic
cancer
prolifer
glioma
epithelialmesenchym
transit
hepatocellular
carcinoma
macrophag
chemotaxi
basallik
breast
cancer
found
critic
target
oncogen
phosphoinositid
signal
pathway
associ
stem
celllik
trait
howev
none
protumor
effect
confirm
gene
target
anim
carcinogenesi
model
contradictori
result
suggest
may
dual
role
cancer
like
depend
type
cancer
cell
produc
particular
tumor
cell
infiltr
macrophag
fibroblast
endotheli
cell
genet
studi
mice
human
necessari
clarifi
contextdepend
find
sever
line
evid
indic
could
local
system
marker
cancerrel
inflamm
upregul
gene
express
observ
associ
stromal
signatur
ovarian
cancer
describ
aggress
breast
cancer
distant
bone
metastas
anaplast
thyroid
carcinoma
soft
tissu
liposarcoma
prostat
cancer
glioblastoma
increas
circul
level
observ
myeloprolif
neoplasm
soft
tissu
sarcoma
lung
cancer
pancreat
carcinoma
glioma
hepatocellular
carcinoma
pancreat
carcinoma
high
level
associ
advanc
clinic
stage
poor
overal
surviv
cohort
patient
invas
ductal
pancreat
carcinoma
stage
iii
iv
plasmat
crp
level
similarli
associ
worst
prognosi
differ
studi
analyz
role
biomark
lung
cancer
proteom
effort
planqu
et
al
report
produc
lung
cancer
cell
result
confirm
patient
lung
cancer
plasma
level
result
significantli
increas
compar
healthi
subject
subsequ
observ
circul
level
relat
diseas
aggress
progress
irrespect
subtyp
histotyp
lung
cancer
addit
roc
analysi
indic
could
discrimin
cancer
patient
heavi
smoker
high
risk
lung
cancer
similarli
high
level
correl
wors
progressionfre
surviv
patient
lung
cancer
chronic
obstruct
pulmonari
diseas
overal
surviv
diseasefre
surviv
smallcel
lung
carcinoma
sclc
recent
studi
individu
high
risk
lung
cancer
demonstr
level
predict
patholog
occurr
patient
cohort
develop
resect
lung
cancer
preoper
plasma
level
higher
compar
cancerfre
heavi
smoker
predictor
outcom
prostat
cancer
patient
circul
level
higher
compar
patient
prostat
inflamm
serum
level
prostatespecif
antigen
psa
crp
differ
two
group
crc
circul
level
significantli
increas
compar
healthi
individu
patient
colorect
polyp
repres
independ
prognost
factor
crc
patient
level
reduc
discharg
surgeri
subsequ
increas
followup
associ
recurr
preoper
level
significantli
associ
clinic
stage
better
postop
prognosi
cohort
primari
crc
patient
anoth
small
group
crc
patient
serum
level
combin
vegf
level
effici
predict
relaps
case
sinc
epigenet
studi
show
silenc
colorect
tumor
cell
increas
plasma
level
patient
reason
reflect
cancerrel
inflamm
associ
tumor
growth
patient
hepatocellular
carcinoma
hcc
show
higher
level
individu
fibrosi
interestingli
patient
aa
genotyp
result
higher
plasma
level
also
significantli
associ
presenc
hcc
besid
evalu
solubl
biomark
cancer
report
also
investig
express
cancer
tissu
hepatocellular
carcinoma
express
analyz
liver
resect
tumor
adjac
normal
tissu
higher
express
observ
tumor
area
express
correl
advanc
stage
larger
tumor
size
presenc
intrahepat
metastas
portal
vein
tumor
thrombosi
liver
cirrhosi
overal
high
express
tumor
tissu
hcc
associ
lower
surviv
surgeri
immunohistochem
analysi
tissu
specimen
lung
cancer
reveal
interstiti
express
neoplast
area
associ
shorter
surviv
stain
observ
normal
lung
parenchyma
tissu
sampl
prostat
cancer
patient
express
higher
level
compar
patient
prostat
inflamm
overal
data
report
strongli
suggest
overexpress
local
system
differ
neoplast
condit
could
like
repres
novel
promis
prognost
factor
cancer
patient
particular
discuss
giacomini
et
al
origin
endotheli
cell
tumorassoci
fibroblast
infiltr
myeloid
cell
like
reflect
microenviron
system
inflamm
associ
tumor
progress
involv
pathogenesi
inde
role
neoplast
transform
growth
shown
depend
context
influenc
properti
interact
differ
molecul
tumor
environ
base
genet
studi
mice
human
genet
associ
wellrecogn
mediat
innat
resist
select
infect
act
modul
complement
activ
opson
microb
facilit
clearanc
phagocytosi
moreov
interact
fibrinogenlik
collagenlik
domain
ficolin
collectin
amplifi
recognit
potenti
humor
innat
immun
figur
line
evid
provid
ration
therapeut
diagnost
translat
molecul
infecti
condit
sever
studi
present
review
also
indic
involv
tissu
remodel
repair
steril
condit
recognit
matrix
molecul
regul
thrombot
respons
fibrin
remodel
thu
play
nonredund
role
orchestr
tissu
repair
process
figur
humor
prm
interact
ecm
compon
eg
collectin
crp
sap
contain
collagen
fibrinogenlik
domain
eg
ficolin
mbl
collectin
sever
ecm
molecul
recogn
microbi
moieti
opson
activ
eg
fibronectin
mindin
osteopontin
vitronectin
line
evid
support
view
inflamm
innat
immun
haemostasi
tissu
repair
function
link
recognit
microbi
moieti
extracellular
matrix
molecul
humor
arm
innat
immun
evolutionarili
conserv
studi
report
final
show
involv
tune
carcinogenesi
modul
cancerrel
inflamm
angiogenesi
specif
cancer
type
figur
howev
studi
propos
specif
model
protumorigen
function
promot
tumor
cell
migrat
invas
macrophag
infiltr
suggest
may
differ
function
carcinogenesi
depend
tissu
cancer
type
possibl
cell
stimulusdepend
glycosyl
sialyl
profil
need
dissect
cancer
consid
nonheal
wound
sinc
woundheal
respons
favor
tumor
growth
activ
tumor
microenviron
includ
extravascular
deposit
fibrin
act
provision
stroma
stromal
immun
cell
migrat
angiogenesi
ecm
deposit
remodel
fibrin
degrad
vascular
resorpt
collagen
synthesi
result
format
dens
fibrou
connect
tissu
scar
wound
desmoplasia
cancer
respons
similar
tumor
wound
tumor
selflimit
interact
fibrin
matrix
complement
compon
regul
main
common
process
tissu
repair
tumorpromot
angiogenesi
inflamm
tabl
thu
suggest
role
tissu
repair
cancer
function
associ
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
